有研粉材(688456) - 2025 Q4 - 年度业绩
2026-02-12 07:55
Financial Performance - In 2025, the total operating revenue reached CNY 3,902.22 million, a year-on-year increase of 20.85%[3] - Operating profit for the year was CNY 77.35 million, reflecting an 18.58% increase compared to the previous year[3] - The total profit amounted to CNY 77.55 million, up 20.10% year-on-year[3] - Net profit attributable to shareholders of the parent company was CNY 70.91 million, a 19.41% increase from the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 65.46% to CNY 54.45 million[3] - Basic earnings per share increased to CNY 0.68, representing a 19.30% growth[3] Assets and Equity - Total assets at the end of the reporting period were CNY 2,176.36 million, a 26.37% increase from the beginning of the period[4] - Shareholders' equity attributable to the parent company rose to CNY 1,267.63 million, a 5% increase[6] - The net asset value per share attributable to shareholders of the parent company was CNY 12.23, reflecting a 5% increase[4] Sales and Market Factors - The increase in profits was primarily driven by higher sales volumes, despite rising raw material prices[5]
普源精电(688337) - 2025 Q4 - 年度业绩
2026-02-12 07:55
Financial Performance - The total operating revenue for 2025 reached RMB 900.23 million, representing a year-on-year increase of 16.04% compared to RMB 775.83 million in the previous year[3] - The net profit attributable to the parent company was RMB 85.20 million, a decrease of 7.69% from RMB 92.30 million in the previous year[3] - The net profit attributable to the parent company after deducting non-recurring gains and losses was RMB 37.60 million, down 35.51% from RMB 58.30 million in the previous year[3] - Basic earnings per share decreased by 10.20% to RMB 0.44 from RMB 0.49 in the previous year[3] - The total profit for the year was RMB 89.33 million, reflecting a year-on-year increase of 16.29% from RMB 76.82 million[3] - The weighted average return on net assets decreased by 0.42 percentage points to 2.69% from 3.11% in the previous year[3] Assets and Investments - Total assets at the end of the reporting period were RMB 3,579.33 million, a decrease of 7.10% from RMB 3,852.92 million at the beginning of the period[3] - Increased R&D investment during the reporting period impacted net profit, with expenses for personnel, materials, and equipment rising compared to the previous year[7] Product Development and Market Performance - The company launched several innovative products in 2025, including the DNA5000/6000 series vector network analyzers and the MHO900 high-resolution digital oscilloscope, which contributed positively to revenue growth[6] - The company experienced a significant increase in orders from key clients in the optical communication sector, driving revenue growth in related product lines[6]
盟升电子(688311) - 2025 Q4 - 年度业绩预告
2026-02-12 07:55
特此公告。 东方金诚国际信用评估有限公司 东方金诚国际信用评估有限公司关于 成都盟升电子技术股份有限公司 2025 年度业绩预亏的关注公告 1 东方金诚公告【2026】0069 号 东方金诚国际信用评估有限公司(以下简称"东方金诚")受托对成都盟升电子技术股份有限 公司(以下简称"盟升电子"或"公司")及其发行的"成都盟升电子技术股份有限公司向不特定 对象发行可转换公司债券"(以下简称"盟升转债")进行了信用评级。2025 年 6 月 23 日,东方 金诚对盟升电子及"盟升转债"进行了定期跟踪评级,下调公司主体信用等级为 A,评级展望稳定, 下调"盟升转债"信用等级为 A,评级结果自报告出具日起生效,在受评债项的存续期内有效。 东方金诚关注到,2026 年 1 月 31 日,盟升电子发布了《成都盟升电子技术股份有限公司 2025 年年度业绩预告》(以下简称"业绩预告")。业绩预告中披露,预计公司 2025 年年度实现归属 于母公司所有者的净利润为-1800.00 万元到-1200.00 万元,与上年同期相比,亏损金额减少 25364.66 万元到 25964.66 万元;预计 2025 年年度实现归属于母公司 ...
金橙子(688291) - 2025 Q4 - 年度业绩
2026-02-12 07:55
证券代码:688291 证券简称:金橙子 公告编号:2026-002 北京金橙子科技股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载2025年度主要财务数据为初步核算数据,未经会计师事务所审计, 具体数据以北京金橙子科技股份有限公司(以下简称"公司")2025年年度的定 期报告为准,提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位:万元 报告期末,公司总资产104,141.06万元,较报告期初增加6.03%;归属于母 公司的所有者权益95,700.20万元,较报告期初增加3.47%。 | | | | 增减变动 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 幅度 | | | | | (%) | | 营业总收入 | 25,339.82 | 21,212.38 | 19.46 | | 营业利润 | 3,765.73 | 2,459.11 | 53.13 | | 利润总额 | 3,749.48 | 2,473 ...
帝欧水华(002798) - 2025 Q4 - 年度业绩预告
2026-02-12 07:50
Financial Performance - In 2025, the company expects a net loss attributable to shareholders between -590 million and -460 million RMB, with a net loss excluding non-recurring items between -550 million and -420 million RMB[2]. - The company's operating revenue has declined due to a continuous contraction in the engineering channel business[2]. Asset Management - The company plans to conduct impairment tests on various assets due to multiple factors affecting performance, which may lead to impairment provisions[2]. Financial Expenses - Financial expenses related to the issued convertible bonds are estimated at approximately 82.47 million RMB for the current period[2]. Gross Margin Improvement - Despite the revenue decline, the overall gross margin has improved year-on-year due to deepening distribution channels, optimizing product structure, and enhancing internal operational management[2].
卫宁健康(300253) - 2025 Q4 - 年度业绩预告
2026-02-12 07:46
Financial Performance - The company expects a net loss attributable to shareholders for 2025 between RMB 390 million and RMB 320 million, compared to a profit of RMB 87.89 million in the same period last year [2]. - The projected net loss after deducting non-recurring gains and losses is expected to be between RMB 374 million and RMB 304 million, down from a profit of RMB 124.18 million in the previous year [2]. - The decline in performance is attributed to multiple factors including macroeconomic conditions, fluctuations in industry demand, and intensified market competition [3]. - The company's overall revenue has decreased due to the WiNEX product not yet generating significant income during its upgrade and replacement phase [3]. - The company has faced additional pressures from asset impairment provisions, goodwill impairment, and tax payments, contributing to profit declines [4]. Cash Flow and Liquidity - As of September 2025, the company had cash reserves of RMB 1.224 billion, indicating relatively sufficient liquidity [4]. - Cash flows from operating and investing activities showed a net outflow during the first nine months of 2025, raising concerns about cash flow stability under current operating conditions [4]. Credit Rating and Financial Management - The company's credit rating remains at AA with a stable outlook, reflecting ongoing monitoring of the healthcare information technology sector and the company's governance and financial status [4]. - The rating agency will continue to track developments in the healthcare information technology industry and their potential impact on the company's credit rating and outlook [4]. - The company’s leverage status is rated 9/9, indicating strong financial leverage management despite the current challenges [6].
长光华芯(688048) - 2025 Q4 - 年度业绩
2026-02-11 10:00
证券代码:688048 证券简称:长光华芯 公告编号:2026-004 苏州长光华芯光电技术股份有限公司 2025 年度业绩快报 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载苏州长光华芯光电技术股份有限公司(以下简称"长光华芯"或 "公司")2025 年度主要财务数据为初步核算数据,未经会计师事务所审计, 具体数据以公司 2025 年年度的定期报告为准,提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 二、经营业绩和财务状况情况说明 (一)报告期的经营情况、财务状况及影响经营业绩的主要因素 2025 年度公司实现营业收入 46,840.90 万元,同比上升 71.81%;实现归属 于母公司所有者的净利润 1,952.26 万元,实现归属于母公司所有者的扣除非经 常性损益的净利润-3,616.33 万元;报告期末,公司总资产 335,998.57 万元, 较报告期初上升 1.75%,归属于母公司的所有者权益 300,522.62 万元,较报告 期初上升 0.65%。 报告期内,公司持续深耕高功率半 ...
中草香料(920016) - 2025 Q4 - 年度业绩
2026-02-11 09:55
Financial Performance - The company's operating revenue for 2025 is approximately CNY 234.30 million, representing a year-on-year increase of 5.47% compared to CNY 222.15 million in the previous year[4]. - The total profit for the period is approximately CNY 23.86 million, showing a significant decline of 45.58% from CNY 43.83 million in the previous year[4]. - Net profit attributable to shareholders of the listed company is approximately CNY 20.75 million, down 43.34% from CNY 36.63 million year-on-year[4]. - Basic earnings per share decreased to CNY 0.27, a decline of 52.63% compared to CNY 0.57 in the previous year[4]. Assets and Equity - Total assets at the end of the reporting period are approximately CNY 631.35 million, reflecting a growth of 10.87% from CNY 569.47 million at the beginning of the period[4]. - Shareholders' equity attributable to the listed company is approximately CNY 384.56 million, an increase of 4.82% from CNY 366.88 million[4]. Market Conditions and Challenges - The decline in net profit is primarily attributed to increased competition in the cooling agent market and a significant drop in product prices, leading to reduced gross margins[7]. - Financial costs have increased due to interest expenses from project loans, adding pressure on overall costs[7]. Strategic Focus - The company is focusing on technological innovation and optimizing product structure while advancing the trial production of a project with an annual capacity of 2,600 tons of cooling agents and fragrance raw materials[6]. Cautionary Note - The company warns that the financial data presented is preliminary and has not been audited, urging investors to be cautious[9].
北矿检测(920160) - 2025 Q4 - 年度业绩
2026-02-11 09:55
证券代码:920160 证券简称:北矿检测 公告编号:2026-002 北矿检测技术股份有限公司 2025 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示:本公告所载 2025 年年度主要财务数据为初步核算数据,未经会 计师事务所审计,具体数据以公司 2025 年年度报告中披露的数据为准,提请投 资者注意投资风险。 一、2025 年年度主要财务数据和指标 单位:元 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 187,389,493.62 | 148,019,369.76 | 26.60% | | 利润总额 | 87,427,317.59 | 62,933,233.91 | 38.92% | | 归属于上市公司股 | 73,928,798.65 | 55,132,475.61 | 34.09% | | 东的净利润 | | | | | 归属于上市公司股 | 72,315,598.81 | 50, ...
晶晨股份(688099) - 2025 Q4 - 年度业绩
2026-02-11 09:45
证券代码:688099 证券简称:晶晨股份 公告编号:2026-006 晶晨半导体(上海)股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载2025年度主要财务数据为初步核算数据,未经会计师事务所审计, 具体数据以晶晨半导体(上海)股份有限公司(以下简称"公司")2025年年度 报告中披露的数据为准,提请投资者注意投资风险。 一、2025 年全年主要财务数据和指标 单位:人民币 万元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度(%) | | --- | --- | --- | --- | | 营业总收入 | 679,323.36 | 592,631.53 | 14.63 | | 营业利润 | 91,209.13 | 85,230.15 | 7.02 | | 利润总额 | 91,168.18 | 85,181.45 | 7.03 | | 归属于母公司所有者的净利润 | 87,123.89 | 82,192.14 | 6.00 | | 归属于母公司所有者的扣除非 经 ...